Position in UTHR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,083,336
+$704,065 QoQ
Shares Held
3,845
+65.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#370
of 877 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 80%
Shared 14%
None 6%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $13,041,183 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
391,297 | $3,650,801 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
3,845 | $2,083,336 | |
| 3 | VTRS |
Viatris Inc
|
74,919 | $1,189,713 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
15,478 | $989,818 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
56,536 | $906,272 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,342 | $900,340 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
7,965 | $883,637 | |
| 8 | ZTS |
Zoetis Inc.
|
9,906 | $711,845 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,083,336 | 3,845 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,379,271 | 2,326 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $907,746 | 1,863 | Shares | Sole | 2026-02-10 | |
| 2024-12-31 | $3,600,732 | 10,205 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,561,640 | 9,939 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,102,677 | 9,740 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,265,498 | 9,862 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||